Mathieu Vautier
YOU?
Author Swipe
View article: Impact of conventional and biological disease-modifying anti-rheumatic drugs on arterial lesions in Takayasu arteritis
Impact of conventional and biological disease-modifying anti-rheumatic drugs on arterial lesions in Takayasu arteritis Open
Background The definition of Takayasu arteritis (TAK) remission and disease activity is still unclear. Vascular imaging is an essential tool for following-up patients. Herein, we aimed to compare the evolution of vascular lesions (i.e. ves…
View article: Outcome and prognosis of isolated carotid vasculitis
Outcome and prognosis of isolated carotid vasculitis Open
Carotid vasculitis may occur as a topographically limited lesion and is associated with significant rate of vascular complications.
View article: Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study Open
Objectives In this large multicentre study, we compared the effectiveness and safety of tocilizumab intravenous versus subcutaneous (SC) in 109 Takayasu arteritis (TAK) patients. Methods We conducted a retrospective multicentre study in re…
View article: Prevalence and clinical features of COVID-19 in a large cohort of 199 patients with sarcoidosis
Prevalence and clinical features of COVID-19 in a large cohort of 199 patients with sarcoidosis Open
International audience
View article: Correlation between Ultra-Wide-Field Retinal Imaging Findings and Vascular Supra-Aortic Changes in Takayasu Arteritis
Correlation between Ultra-Wide-Field Retinal Imaging Findings and Vascular Supra-Aortic Changes in Takayasu Arteritis Open
(1) Background: Takayasu arteritis (TA) is a chronic inflammatory large-vessel vasculitis. Ultra-wide-field imaging allows describing the retinal lesions in these patients and correlating them with vascular supra-aortic stenosis. (2) Metho…
View article: Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients Open
Objective To assess the safety and the efficacy of TNF-α antagonists and tocilizumab in patients with Takayasu arteritis (TAK). Methods A total of 209 patients with TAK [median age 29 years (interquartile range 7–62)], 186 (89%) females] w…
View article: Vascular Behçet's disease: a comparative study from Turkey and France
Vascular Behçet's disease: a comparative study from Turkey and France Open
Almost half of patients relapsed of VBD within 2 years after the first vascular event. Immunosuppressants decrease VBD relapses.
View article: Spectrum and Outcome of Noninfectious Aortitis
Spectrum and Outcome of Noninfectious Aortitis Open
Objective To assess the spectrum and long-term outcome of patients with noninfectious aortitis. Methods We performed a retrospective multicenter study of 353 patients (median age at diagnosis was 62 [IQR 46–71] yrs and 242 [68.6%] patients…
View article: Apremilast in Refractory Behçet’s Syndrome: A Multicenter Observational Study
Apremilast in Refractory Behçet’s Syndrome: A Multicenter Observational Study Open
Objective Mucocutaneous and joint disorders are the most common manifestations in Behçet’s syndrome (BS) and are frequently clustered in the so-called minor forms of BS. There remains a need for safe and effective treatment for joint lesio…
View article: Medium- and Large-Vessel Vasculitis
Medium- and Large-Vessel Vasculitis Open
Systemic vasculitides are multisystem blood vessel disorders, which are defined by the size of the vessel predominantly affected, namely small, medium, or large vessels. The term “large vessel” relates to the aorta and its major branches; …
View article: Performance of serum apolipoprotein-A1 as a sentinel of Covid-19
Performance of serum apolipoprotein-A1 as a sentinel of Covid-19 Open
Background Since 1920, a decrease in serum cholesterol has been identified as a marker of severe pneumonia. We have assessed the performance of serum apolipoprotein-A1, the main transporter of HDL-cholesterol, to identify the early spread …
View article: Neutrophil–Platelet and Monocyte–Platelet Aggregates in COVID-19 Patients
Neutrophil–Platelet and Monocyte–Platelet Aggregates in COVID-19 Patients Open
International audience
View article: Abstract Supplement ACR Convergence 2020
Abstract Supplement ACR Convergence 2020 Open
For a searchable version of these abstracts, please visit www.acrabstracts.org .
View article: Performance of serum apolipoprotein-A1 as a sentinel of Covid-19
Performance of serum apolipoprotein-A1 as a sentinel of Covid-19 Open
Background Since 1920, a decrease in serum cholesterol has been identified as a marker of severe pneumonia. We have assessed the performance of serum apolipoprotein-A1, the main transporter of HDL-cholesterol, to identify the early spread …
View article: Prevalence and clinical features of COVID-19 in a large cohort of 199 patients with sarcoidosis
Prevalence and clinical features of COVID-19 in a large cohort of 199 patients with sarcoidosis Open
Objective: To investigate the prevalence, clinical features and outcomes of coronavirus disease 2019 (COVID-19) among sarcoidosis patients. Methods: We retrospectively collected features of COVID-19 in a cohort of patients with sarcoidosis…
View article: Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labelled trial
Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labelled trial Open
Objectives To assess long term efficacy of tocilizumab in treatment-naive patients with Takayasu arteritis (TAK). Methods Prospective open-labelled trial in naïve patients with TAK who received steroids at the dose of 0.7 mg/kg/day and 7 i…
View article: Abstract Supplement 2019 ACR/ARP Annual Meeting
Abstract Supplement 2019 ACR/ARP Annual Meeting Open
For a searchable version of these abstracts, please visit www.acrabstracts.org .